Intratumor MAPK and PI3K signaling pathway heterogeneity in glioblastoma tissue correlates with CREB signaling and distinct target gene signatures
| Autor: | Andrew H. Kaye, Stanley S. Stylli, Gulay Filiz, Paul M. Daniel, Martin James Tymms, Theo Mantamadiotis, Robert G. Ramsay |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
MAPK/ERK pathway Cell signaling MAP Kinase Signaling System medicine.medical_treatment Clinical Biochemistry CREB Pathology and Forensic Medicine Targeted therapy 03 medical and health sciences Genetic Heterogeneity Phosphatidylinositol 3-Kinases medicine Humans Cyclic AMP Response Element-Binding Protein Molecular Biology Transcription factor PI3K/AKT/mTOR pathway Cell Proliferation Regulation of gene expression biology Brain Neoplasms Gene signature Gene Expression Regulation Neoplastic 030104 developmental biology Hyaluronan Receptors biology.protein Cancer research Glioblastoma Transcriptome |
| Zdroj: | Experimental and molecular pathology. 105(1) |
| ISSN: | 1096-0945 |
| Popis: | Limitations in discovering useful tumor biomarkers and drug targets is not only due to patient-to-patient differences but also due to intratumor heterogeneity. Heterogeneity arises due to the genetic and epigenetic variation of tumor cells in response to microenvironmental interactions and cytotoxic therapy. We explored specific signaling pathway activation in glioblastoma (GBM) by investigating the intratumor activation of the MAPK and PI3K pathways. We present data demonstrating a striking preponderance for mutual exclusivity of MAPK and PI3K activation in GBM tissue, where MAPK activation correlates with proliferation and transcription factor CREB activation and PI3K activation correlates with CD44 expression. Bioinformatic analysis of signaling and CREB-regulated target genes supports the immunohistochemical data, showing that the MAPK-CREB activation correlates with proliferative regions. In-silico analysis suggests that MAPK-CREB signaling activates a pro-inflammatory molecular signature and correlates with a mesenchymal GBM subtype profile, while PI3K-CREB activation correlates with the proneural GBM subtype and a tumor cell invasive gene signature. Overall, the data suggests the existence of intratumor subtype heterogeneity in GBM and that using combinations of both MAPK and PI3K drug inhibitors is necessary for effective targeted therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect